Domestically produced novel drugs accounted for more than 80 per cent of market approvals in China in the first half of the year, reflecting a “leap” in the quality of the country’s pharmaceutical innovation, according to a government spokesman.A total of 38 innovative drugs were cleared for sale in the six-month period, of which 31 were home-grown medicines, said Ministry of Industry and Information Technology spokesman Tao Qing, at a media briefing in Beijing on Monday.The approvals, along with a record high of about US$110 billion in out-licensing deals over the period, fully demonstrated that “the innovation quality of China’s pharmaceutical industry has achieved a systemic leap”, Tao said.
SRCSouth China Morning Post
LANGEN
LEANCenter-Right
WORDS109
ENT8
MON · 2026-07-20 · 11:00 GMTBRIEF NSR-2026-0720-94379
NSR-2026-0720-94379News Report·EN·Technology
‘Systemic leap’: China’s drug innovation push yields bumper crop
In the first half of the year, China saw a significant increase in domestically produced novel drugs, with these home-grown medicines accounting for over 80 percent of market approvals. A total of 38 innovative drugs were cleared for sale, with 31 being developed within China.
Julie ZhangSouth China Morning PostFiled 2026-07-20 · 11:00 GMTLean · Center-RightRead · 1 min
South China Morning PostFIG 01
Reading time
1min
Word count
109words
Sources cited
1cited
Entities identified
8entities
Quality score
100%
§ 01
Briefing Summary
AI-generatedNEWSAR · AI
In the first half of the year, China saw a significant increase in domestically produced novel drugs, with these home-grown medicines accounting for over 80 percent of market approvals. A total of 38 innovative drugs were cleared for sale, with 31 being developed within China. This trend, alongside a record US$110 billion in out-licensing deals during the same period, indicates a substantial improvement in the quality of China's pharmaceutical innovation, according to Ministry of Industry and Information Technology spokesman Tao Qing. These developments were announced at a media briefing in Beijing.
Confidence 0.85Sources 1Claims 4Entities 8
§ 02
Article analysis
Model · rule-basedFraming
Technology
Economic Impact
Tone
Measured
AI-assessed
CalmNeutralAlarmist
Factuality
0.70 / 1.00
Factual
LowHigh
Sources cited
1
Limited
FewMany
§ 03
Key claims
4 extracted01
China saw a record high of about US$110 billion in out-licensing deals for drugs in the first half of the year.
statisticMinistry of Industry and Information Technology spokesman Tao Qing
Confidence
1.00
02
The innovation quality of China’s pharmaceutical industry has achieved a systemic leap.
quoteMinistry of Industry and Information Technology spokesman Tao Qing
Confidence
1.00
03
A total of 38 innovative drugs were cleared for sale in the six-month period, of which 31 were home-grown medicines.
statisticMinistry of Industry and Information Technology spokesman Tao Qing
Confidence
1.00
04
Domestically produced novel drugs accounted for more than 80 per cent of market approvals in China in the first half of the year.
statisticMinistry of Industry and Information Technology spokesman Tao Qing
Confidence
1.00
§ 04
Full report
1 min read · 109 words§ 05
Entities
8 identifiedKey playerOppositionContextPositiveNeutralNegative
§ 06
Keywords & salience
7 termsdrug innovation
1.00
pharmaceutical industry
0.90
market approvals
0.80
home-grown medicines
0.70
out-licensing deals
0.60
china
0.50
quality leap
0.40
§ 07
Topic connections
Interactive graph Network visualization showing 51 related topics
View Full Graph Person Organization Location Event|Click node to navigate|Edge numbers = shared articles